According to STAAR Surgical's latest financial reports the company has a price-to-book ratio of 5.43.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 3.95 | -43.3% |
2022-12-31 | 6.96 | -58.58% |
2021-12-31 | 16.8 | -9.25% |
2020-12-31 | 18.5 | 88.75% |
2019-12-31 | 9.81 | -7.86% |
2018-12-31 | 10.6 | -28.72% |
2017-12-31 | 14.9 | 28.13% |
2016-12-31 | 11.7 | 59.03% |
2015-12-31 | 7.33 | -22.76% |
2014-12-31 | 9.49 | -38.93% |
2013-12-31 | 15.5 | 122.04% |
2012-12-31 | 7.00 | -45.46% |
2011-12-31 | 12.8 | 34.49% |
2010-12-31 | 9.54 | 86.76% |
2009-12-31 | 5.11 | 16.65% |
2008-12-31 | 4.38 | 103.82% |
2007-12-31 | 2.15 | -61.99% |
2006-12-31 | 5.65 | 15.94% |
2005-12-31 | 4.88 | 42.52% |
2004-12-31 | 3.42 | -41.5% |
2003-12-31 | 5.85 | 182.43% |
2002-12-31 | 2.07 |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Novartis NVS | 5.27 | -2.86% | ๐จ๐ญ Switzerland |
Abbott Laboratories ABT | 4.70 | -13.40% | ๐บ๐ธ USA |
Cooper Companies COO | 2.53 | -53.39% | ๐บ๐ธ USA |
Atrion ATRI | 3.30 | -39.12% | ๐บ๐ธ USA |
SurgePays SURG | 2.76 | -49.20% | ๐บ๐ธ USA |